Plasma &bgr;-Amyloid 1-40 Is Associated With the Diffuse Small Vessel Disease Subtype

No abstract is available for this paper.

• Publication year

  2009

• Venue

  Stroke

• Publication date

  2009-10-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1161/STROKEAHA.109.559641PMID 19696416
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Monocyte count is an underlying marker of lacunar subtype of hypertensive small vessel disease

  2008cited by this paper
• Genes, endothelial function and cerebral small vessel disease in man

  2008cited by this paper
• Association of Low Plasma Aβ42/Aβ40 Ratios With Increased Imminent Risk for Mild Cognitive Impairment and Alzheimer Disease

  2007cited by this paper
• Early Arterial Study in the Prediction of Mortality After Acute Ischemic Stroke

  2007cited by this paper
• Plasma β amyloid and impaired CO2-induced cerebral vasomotor reactivity

  2007cited by this paper
• Plasma beta amyloid and impaired CO2-induced cerebral vasomotor reactivity.

  2007cited by this paper
• Association of low plasma Abeta42/Abeta40 ratios with increased imminent risk for mild cognitive impairment and Alzheimer disease.

  2007cited by this paper
• Asymmetric Dimethylarginine in Cerebral Small Vessel Disease

  2007cited by this paper
• Plasma β-amyloid and white matter lesions in AD, MCI, and cerebral amyloid angiopathy

  2006cited by this paper
• Plasma beta-amyloid and white matter lesions in AD, MCI, and cerebral amyloid angiopathy.

  2006cited by this paper
• White Matter Lesions in an Unselected Cohort of the Elderly: Molecular Pathology Suggests Origin From Chronic Hypoperfusion Injury

  2006cited by this paper
• Risk factor profile of cerebral small vessel disease and its subtypes

  2006cited by this paper
• Circulating beta amyloid protein is elevated in patients with acute ischemic stroke

  2005cited by this paper
• Markers of Endothelial and Hemostatic Activation and Progression of Cerebral White Matter Hyperintensities: Longitudinal Results of the Austrian Stroke Prevention Study

  2005cited by this paper
• Plasma amyloid β, apolipoprotein E, lacunar infarcts, and white matter lesions

  2004cited by this paper
• Age but Not Diagnosis Is the Main Predictor of Plasma Amyloid β-Protein Levels

  2003cited by this paper
• Markers of endothelial dysfunction in lacunar infarction and ischaemic leukoaraiosis.

  2003cited by this paper
• Is Breakdown of the Blood-Brain Barrier Responsible for Lacunar Stroke, Leukoaraiosis, and Dementia?

  2003cited by this paper
• Age but not diagnosis is the main predictor of plasma amyloid beta-protein levels.

  2003cited by this paper
• Patterns of cerebral blood flow reduction in patients with ischemic leukoaraiosis

  2002cited by this paper
• Serum Creatinine Levels Correlate With Plasma Amyloid &bgr; Protein

  2002cited by this paper
• Serum creatinine levels correlate with plasma amyloid β protein

  2002cited by this paper
• Alzheimer's disease: genes, proteins, and therapy.

  2001cited by this paper
• Exogenous Aβ1–40 Reproduces Cerebrovascular Alterations Resulting from Amyloid Precursor Protein Overexpression in Mice

  2000cited by this paper
• Abeta 1-40-related reduction in functional hyperemia in mouse neocortex during somatosensory activation.

  2000cited by this paper
• Reduced vasomotor reactivity in cerebral microangiopathy : a study with near-infrared spectroscopy and transcranial Doppler sonography.

  2000cited by this paper
• Cleavage of amyloid precursor protein elicited by chronic cerebral hypoperfusion.

  2000cited by this paper
• SOD1 rescues cerebral endothelial dysfunction in mice overexpressing amyloid precursor protein

  1999cited by this paper
• Longitudinal study of cerebrospinal fluid levels of tau, A beta1-40, and A beta1-42(43) in Alzheimer's disease: a study in Japan.

  1998cited by this paper
• Longitudinal study of cerebrospinal fluid levels of tau, Aβ1–40, and Aβ1–42(43) in Alzheimer's disease: A study in Japan

  1998cited by this paper
• Increased Susceptibility to Ischemic Brain Damage in Transgenic Mice Overexpressing the Amyloid Precursor Protein

  1997cited by this paper
• Pathogenesis of leukoaraiosis: a review.

  1997cited by this paper
• Genetic factors in Alzheimer's disease: A review of recent advances

  1996cited by this paper
• Brain Parenchymal and Microvascular Amyloid in Alzheimer's Disease

  1996cited by this paper
• Apolipoprotein E ϵ4 and cerebral hemorrhage associated with amyloid angiopathy

  1995cited by this paper
• Apolipoprotein E epsilon 4 and cerebral hemorrhage associated with amyloid angiopathy.

  1995cited by this paper
• Classification of Subtype of Acute Ischemic Stroke: Definitions for Use in a Multicenter Clinical Trial

  1993cited by this paper
• Two Clinically Distinct Lacunar Infarct Entities?: A Hypothesis

  1993cited by this paper
• Leukoaraiosis and dementia.

  1990cited by this paper
• Interrater reliability of the NIH stroke scale.

  1989cited by this paper
• MR signal abnormalities at 1.5 T in Alzheimer's dementia and normal aging.

  1987cited by this paper
• Capsular infarcts: the underlying vascular lesions.

  1979cited by this paper

• Changes of fatty acid metabolism in FA 26:0, FA 22:2 and FA 24:1 are associated with leukoaraiosis in the elderly.

  2026cites this paper
• Correlation between mild behavioral impairment and peripheral blood biomarkers in patients with mild cognitive impairment

  2025cites this paper
• Roles of neuroimaging markers and biomarkers in cerebral small vessel disease and their associations with cognitive function

  2025cites this paper
• Differential blood-based biomarkers of subcortical and deep brain small vessel disease

  2024cites this paper
• A Scoping Review on Biomarkers of Endothelial Dysfunction in Small Vessel Disease: Molecular Insights from Human Studies

  2023cites this paper
• Vascular Considerations for Amyloid Immunotherapy

  2022cites this paper
• Grip Strength, Gait Speed and Plasma Markers of Neurodegeneration in Asymptomatic Middle-aged and Older Adults

  2022cites this paper
• Blood Pressure Level Is Associated With Changes in Plasma Aβ1 –40 and Aβ1–42 Levels: A Cross-sectional Study Conducted in the Suburbs of Xi’an, China

  2021cites this paper
• Biomarkers Related to Endothelial Dysfunction and Vascular Cognitive Impairment: A Systematic Review

  2020cites this paper
• Distinct Uptake Kinetics of Alzheimer Disease Amyloid-β 40 and 42 at the Blood-Brain Barrier Endothelium

  2020cites this paper
• Lower serum expression of miR-181c-5p is associated with increased plasma levels of amyloid-beta 1–40 and cerebral vulnerability in normal aging

  2019cites this paper
• [Lacunar stroke].

  2019cites this paper
• Periodontitis is associated with systemic inflammation and vascular endothelial dysfunction in patients with lacunar infarct.

  2018cites this paper
• Chronic oral infection: An emerging risk factor of cerebral small vessel disease.

  2018cites this paper
• Elevation of Plasma Amyloid-β Level is More Significant in Early Stage of Cognitive Impairment: A Population-Based Cross-Sectional Study

  2018cites this paper
• Aβ1-40 and Aβ1-42 Plasmatic Levels In Stroke: Influence of Pre-Existing Cognitive Status and Stroke Characteristics.

  2017cites this paper
• Pulse pressure is associated with plasma amyloid-&bgr; transport dysfunction

  2017cites this paper
• Cardiovascular Alterations in Patients with Dementia

  2017cites this paper
• Brain Perivascular Macrophages Initiate the Neurovascular Dysfunction of Alzheimer A&bgr; Peptides

  2017cites this paper
• Cerebrovascular pathology in Down syndrome and Alzheimer disease

  2017cites this paper
• Targeting Hypertension to Manage Alzheimers Disease: Rational andPromise

  2016cites this paper
• Blood and CSF biomarkers in brain subcortical ischemic vascular disease: Involved pathways and clinical applicability

  2016cites this paper
• Homozygous carriers of APP A713T mutation in an autosomal dominant Alzheimer disease family

  2015cites this paper
• The presence of cerebral and/or systemic endothelial dysfunction in patients with leukoaraiosis - a case control pilot study

  2015cites this paper
• Vascular and amyloid pathologies are independent predictors of cognitive decline in normal elderly

  2015cites this paper
• Modeling the Role of the Glymphatic Pathway and Cerebral Blood Vessel Properties in Alzheimer’s Disease Pathogenesis

  2015cites this paper
• Selective Astrocytic Endothelin-1 Overexpression Contributes to Dementia Associated with Ischemic Stroke by Exaggerating Astrocyte-Derived Amyloid Secretion

  2015cites this paper
• Plasma β‐amyloid 40 levels are positively associated with mortality risks in the elderly

  2015cites this paper
• The role of proteotoxic stress in vascular dysfunction in the pathogenesis of Alzheimer’s disease

  2015cites this paper
• Soluble amyloid-β levels and late-life depression.

  2014cites this paper
• Research Article Plasma b-amyloid 40 levels are positively associated with mortality risks in the elderly

  2014cites this paper
• Advancements in understanding the mechanisms of symptomatic lacunar ischemic stroke: translation of knowledge to prevention strategies

  2014cites this paper
• Regarding long-term statin therapy: are we trading stronger hearts for weaker brains?

  2014cites this paper
• Prognostic Value of Plasma &bgr;-Amyloid Levels in Patients With Acute Intracerebral Hemorrhage

  2014cites this paper
• Hypertension: A Harbinger of Stroke and Dementia

  2013cites this paper
• Association Healthcare Professionals From the American Heart Association/American Stroke Vascular Contributions to Cognitive Impairment and Dementia : A Statement for

  2013cites this paper
• Costantino Iadecola Hypertension : A Harbinger of Stroke and Dementia

  2013cites this paper
• Strength and weaknesses of cerebrospinal fluid biomarkers in Alzheimer's disease and possible detection of overlaps with frailty process.

  2013cites this paper
• Cognitive profile in patients with a first-ever lacunar infarct with and without silent lacunes: a comparative study

  2013cites this paper
• Effects of β-sheet breaker peptides on altered responses of thoracic aorta in rats' Alzheimer's disease model induced by intraamygdaloid Aβ40.

  2013cites this paper
• Brain and Circulating Levels of A&bgr;1–40 Differentially Contribute to Vasomotor Dysfunction in the Mouse Brain

  2013cites this paper
• Subacute Ischemic Stroke Is Associated With Focal 11C PiB Positron Emission Tomography Retention But Not With Global Neocortical A&bgr; Deposition

  2012cites this paper
• Potential Blood Biomarkers in Age-related Cerebral Small Vessel Disease

  2012cites this paper
• Plasma Amyloid‐BetaPeptides in Acute Cerebral Ischemia: A Pilot Study

  2012cites this paper
• Brain and Circulating Levels of A β 1–40 Differentially Contribute to Vasomotor Dysfunction in the Mouse Brain

  2012cites this paper
• Brain and Circulating Levels of A β 1–40 Differentially Contribute to Vasomotor Dysfunction in the Mouse Brain

  2012cites this paper
• Brain and Circulating Levels of A β 1–40 Differentially Contribute to Vasomotor Dysfunction in the Mouse Brain

  2012cites this paper
• Brain and Circulating Levels of A β 1–40 Differentially Contribute to Vasomotor Dysfunction in the Mouse Brain

  2012cites this paper
• Brain and Circulating Levels of A β 1–40 Differentially Contribute to Vasomotor Dysfunction in the Mouse Brain

  2012cites this paper
• Aβ42 production in brain capillary endothelial cells after oxygen and glucose deprivation.

  2012cites this paper
• Microbleeds relate to altered amyloid-β metabolism in Alzheimer's disease.

  2012cites this paper
• Mixed Cerebrovascular Disease and the Future of Stroke Prevention

  2012cites this paper
• CSF and clinical hallmarks of subcortical dementias: focus on DLB and PDD

  2012cites this paper
• Variability in Blood-Based Amyloid-β Assays: The Need for Consensus on Pre-Analytical Processing

  2012cites this paper
• AHA / ASA Scientific Statement Vascular Contributions to Cognitive Impairment and Dementia

  2011cites this paper
• Vascular Contributions to Cognitive Impairment and Dementia: A Statement for Healthcare Professionals From the American Heart Association/American Stroke Association

  2011cites this paper
• The overlap between neurodegenerative and vascular factors in the pathogenesis of dementia

  2010cites this paper
• Vascular pathology in the aged human brain

  2010cites this paper
• Leukoarajoza jako jedna z postaci choroby małych naczyń mózgowych

  2009cites this paper
• World Journal of Psychiatry

  year unknowncites this paper
• 2 Hypertension November 2013 Alterations in Cerebrovascular Function Induced by HTN

  year unknowncites this paper
• A Harbinger of Stroke and Dementia

  year unknowncites this paper